SEC Filing Details

Document Details

Form
4
Filing Date
Apr 29, 2022
Document Date
Mar 16, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Cumberland Pharmaceuticals, Inc.
Issuer
CUMBERLAND PHARMACEUTICALS INC